Literature DB >> 26405405

Evaluation of Estrogen, Progesterone, and GCDFP-15 Expression in Uterine Leiomyomas.

Havva Erdem1, Feyza Başar1, Nilüfer Kadıoğlu1, Murat Oktay1, Handan Ankaralı2, Ali Yavuzcan3, Anzel Bahadır4, Serdar Dilbaz3.   

Abstract

Approximately, one fourth of women have leiomyomas. Leiomyomas are benign tumors that originated from smooth muscle cells. Estrogen is claimed to relate as a cause but exact mechanism has not fully understood. In this study, 95 leiomyoma cases that have been diagnosed by our department in years between 2010 and 2012 were examined. Age ranges of patients, sizes, locations, and numbers of leiomyomas were identified. Immunohistochemically ER (estrogen), PR (progesterone), and Gross cystic disease fluid protein-15 stains were performed to the paraffin blocks and their percentages of staining were noted. Statistically, submucosal and intramural locations were significantly related to ER and PR (p < 0,001). There were significant relationship between ER and PR in 30-50 years age group (p < 0,001). There were significant relationship between ER, PR and locations (p < 0,001), numbers (p < 0,001), sizes of leiomyomas (below 5 cm; p < 0,001), (between 5 and 10 cm; p = 0,037), larger than 10 cm; p = 0,002). Consequently, relationship between leiomyoma and ER, PR were revealed in this study. Also, relationship between leiomyoma locations and patient ages were identified statistically. There was no immunoreactivity with GCDFP-15 in leiomyomas.

Entities:  

Keywords:  ER; GCDFP-15; PR; Uterine leiomyoma

Year:  2014        PMID: 26405405      PMCID: PMC4579142          DOI: 10.1007/s13224-014-0617-1

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  14 in total

1.  Uterine myoma in postmenopause: a comparison between two therapeutic schedules of HRT.

Authors:  F Polatti; F Viazzo; R Colleoni; R E Nappi
Journal:  Maturitas       Date:  2000-11-30       Impact factor: 4.342

2.  Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women.

Authors:  S Palomba; A Sammartino; C Di Carlo; P Affinito; F Zullo; C Nappi
Journal:  Fertil Steril       Date:  2001-07       Impact factor: 7.329

3.  Malignant transformation of leiomyoma of uterus to leiomyosarcoma with metastasis to ovary.

Authors:  Bhavana Madhukar Bharambe; Kalpana A Deshpande; Sanjay G Surase; Alkesh P Ajmera
Journal:  J Obstet Gynaecol India       Date:  2012-10-05

Review 4.  Clinical features of myomas.

Authors:  Orhan Bukulmez; Kevin J Doody
Journal:  Obstet Gynecol Clin North Am       Date:  2006-03       Impact factor: 2.844

5.  Frequency of fibroid uterus in multipara women in a tertiary care centre in Rawalpindi.

Authors:  Faiza Ibrar; Shazia Riaz; Nasira S Dawood; Alia Jabeen
Journal:  J Ayub Med Coll Abbottabad       Date:  2010 Jul-Sep

6.  Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers.

Authors:  C Leal; R Henrique; P Monteiro; C Lopes; M J Bento; C P De Sousa; P Lopes; S Olson; M D Silva; D L Page
Journal:  Hum Pathol       Date:  2001-05       Impact factor: 3.466

Review 7.  Sex steroidal regulation of uterine leiomyoma growth and apoptosis.

Authors:  T Maruo; N Ohara; J Wang; H Matsuo
Journal:  Hum Reprod Update       Date:  2004 May-Jun       Impact factor: 15.610

8.  Treatment of abnormal uterine bleeding with the gynecologic resectoscope.

Authors:  S P Serden; P G Brooks
Journal:  J Reprod Med       Date:  1991-10       Impact factor: 0.142

Review 9.  Etiology and pathogenesis of uterine leiomyomas: a review.

Authors:  Gordon P Flake; Janet Andersen; Darlene Dixon
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

Review 10.  Uterine fibroids: current perspectives.

Authors:  Aamir T Khan; Manjeet Shehmar; Janesh K Gupta
Journal:  Int J Womens Health       Date:  2014-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.